|
|
|
|
|
SM645-50
|
Amylin, rat
|
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
|
|
|
SM645-50
|
Amylin, rat
|
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
|
|
|
SM641-81
|
Amyloid Blocker
|
Acetyl-Gln-Lys-Leu-Val-Phe-Phe-NH2
|
|
|
SM641-64
|
Amyloid Fragment (Pro18,Asp21) (17-21)
|
Leu-Pro-Phe-Phe-Asp-OH
|
|
|
SM641-87
|
Amyloid Precursor
|
7-Methoxycoumarin-4acetyl-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-e-DNP-Lys-Arg-Arg-NH2
|
|
|
SM641-87
|
Amyloid Precursor
|
7-Methoxycoumarin-4acetyl-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-e-DNP-Lys-Arg-Arg-NH2
|
|
|
SM131-41
|
Angiotensin Fragment ( 1-7 ) acetate
|
Asp-Arg-Val-Tyr-Ile-His-Pro-OH
|
|
|
SM137-40
|
Angiotensin I [Asn1,Val5,Asn9], salmon
|
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
|
|
|
SM137-36
|
Angiotensin I [Val5,Asn9], bullfrog
|
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
|
|
|
SM131-63
|
Angiotensin II [Sar1,Ile8]
|
Sarcosine-Arg-Val-Tyr-Ile-His-Pro-Ile-OH
|
|
|
SM131-49
|
Angiotensin II, human
|
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
|
|
|
SM131-65
|
Angiotensin II-[Sar1]
|
Sarcosine-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
|
|
|
SM131-76
|
Angiotensin III, human) / Angiotensin II-[Des Asp1]
|
Arg-Val-Tyr-Ile-His-Pro-Phe-OH
|
|
|
SM131-82
|
Angiotensinogen (1-14) Renin Substrate (porcine)
|
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH
|
|
|
SM640-27
|
APP (354-371)
|
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
|
|
|
SM640-27
|
APP (354-371)
|
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
|
|
|
SM649-10
|
APP Beta Secretase Inhibitor
|
Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-200-Val-Ala-Glu-Phe-OH
|
|
|
SM649-23
|
APP Gamma Secretase Inhibitor
|
3-5difluorophenacetyl-Ala-S-Pheglycine-Methylester
|
|
|
SM649-22
|
APP Gamma Secretase Inhibitor
|
3-5difluorophenacetyl-Ala-S-Pheglycine-t-butylester
|
|
|
SM450-29
|
Arg-Gly-Asp-Ser (RGDS)
|
Arg-Gly-Asp-Ser-OH
|
|
|
SM641-14
|
[Gly22] Beta Amyloid (1-40), human ( Arctic )
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-14
|
[Gly22] Beta Amyloid (1-40), human ( Arctic )
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-22
|
[Gly22] Beta Amyloid (1-42), human (Arctic)
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-22
|
[Gly22] Beta Amyloid (1-42), human (Arctic)
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-45
|
Beta Amyloid [Glu11] (10-16), human
|
Tyr-Glu-Val-His-His-Gln-Lys-OH
|
|
|
SM641-45
|
Beta Amyloid [Glu11] (10-16), human
|
Tyr-Glu-Val-His-His-Gln-Lys-OH
|
|
|
SM641-13
|
Beta Amyloid [Nle35] (1-40), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-050-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-13
|
Beta Amyloid [Nle35] (1-40), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-050-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-13
|
Beta Amyloid [Nle35] (1-40), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-050-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-21
|
Beta Amyloid (10-20), human
|
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH
|
|
|
SM641-21
|
Beta Amyloid (10-20), human
|
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH
|
|
|
SM641-35
|
Beta Amyloid (1-16) [Gln11], human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH
|
|
|
SM641-35
|
Beta Amyloid (1-16) [Gln11], human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH
|
|
|
SM642-36
|
Beta Amyloid (1-16), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH
|
|
|
SM642-36
|
Beta Amyloid (1-16), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH
|
|
|
SM641-19
|
Beta Amyloid (12-28), human
|
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
|
|
|
SM641-19
|
Beta Amyloid (12-28), human
|
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
|
|
|
SM641-17
|
Beta Amyloid (1-28), [Gln11], human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
|
|
|
SM641-17
|
Beta Amyloid (1-28), [Gln11], human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
|
|
|
SM641-17
|
Beta Amyloid (1-28), [Gln11], human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
|
|
|
SM641-88
|
Beta Amyloid (13-16), human
|
His-His-Gln-Lys-OH
|
|
|
SM641-88
|
Beta Amyloid (13-16), human
|
His-His-Gln-Lys-OH
|
|
|
SM642-10
|
Beta Amyloid (1-40), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM642-10
|
Beta Amyloid (1-40), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM642-10
|
Beta Amyloid (1-40), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-01
|
Beta Amyloid [Glu11] (1-40), human - HFIP
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-01
|
Beta Amyloid [Glu11] (1-40), human - HFIP
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
|
|
|
SM641-15
|
Beta Amyloid (1-42), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-15
|
Beta Amyloid (1-42), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-15
|
Beta Amyloid (1-42), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-00
|
Beta Amyloid (1-42), human - HFIP
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-00
|
Beta Amyloid (1-42), human - HFIP
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM642-15
|
Beta Amyloid (1-42), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM642-15
|
Beta Amyloid (1-42), rat
|
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
|
|
|
SM641-20
|
Beta Amyloid (1-43), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH
|
|
|
SM641-20
|
Beta Amyloid (1-43), human
|
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH
|
|
|